OUR SCIENCE

TECHNOLOGY

 

ALL-IN-ONE PERSONALIZED DRUG DISCOVERY PLATFORM

AIMEDBIO SCHEME.png

Created with Biorender.com

t_antibody-development.png

AIMEDBIO develops drugs through strategic antibody development based on patient genome big data. By combining our proprietary antibody screening methods and antibody platform technology (dual antibody, antibody-to-drug junction) with our brain disease-specific models, we are able to develop differentiated brain-specific antibody therapeutics.

antibody 01.png
antibody 02.png
antibody 03.png

Created with Biorender.com

 
t_immunooncology.png

AIMEDBIO focuses on unveiling the mechanism behind how cancer cells evade the immune system by studying macrophage, microglia and lymphocytes. We are also interested in modulating neuro-inflammation as therapeutic approaches targeting brain diseases.

Immunology 01.png

Created with Biorender.com

 
t_hts_hcs.png

AIMEDBIO's High-Throughput/Contents Screening (HTS/HCS) Platform is used to robustly yet efficiently identify novel therapeutics and evaluate drug efficacy by measuring multi-parametric changes: viability, protein level, morphology and more. Its data analysis along with genomic/clinical information enables us to take a step further in precision medicine.

HTS_HCS 01.png
HTS_HCS 02.png

Created with Biorender.com

 
t_pdc_pdx.png

AIMEDBIO currently possesses Patient-derived Cell/Xenograft (PDC/PDX) of over 12 types of carcinomas, among which we have developed more than 152 models of brain tumor PDXs alone. PDC/PDXs produced with tumor tissues derived from patients allow for a successful drug efficacy assessment by representing each individual's heterogeneous characteristics compared to cell lines.  

PDC_PDX 02.png
PDC_PDX 01.png

Created with Biorender.com

 
t_bigdataanalysis.png

AIMEDBIO's partnership with medical institutions, clinical experts, and data analysis experts around the world makes it invaluable. Genome, transcriptome, epigenome, proteome, and drug screening data are used in big data-driven drug discovery and development.

P01_edited.jpg
P06_edited.jpg
P05.JPG
P09.JPG
P07.JPG
P04.JPG
P08.JPG